Kiromic BioPharma Inc. (KRBP)

OTC: KRBP · Real-Time Price · USD

0.20

0.00 (0.05%)

At close: Mar 24, 2025, 3:59 PM

Kiromic BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-26.9M	-20.95M	-34.73M	-25.59M	-19.2M	-3.73M	-3.82M
Depreciation & Amortization	2.23M	2.22M	1.67M	469.8K	200K	87.5K	80.9K
Stock-Based Compensation	597K	141.3K	1.24M	3.76M	13.25M	522.9K	633K
Other Working Capital	-339K	1.82M	562.9K	-710.6K	-386.8K	-25.6K	320.2K
Other Non-Cash Items	4.41M	574.8K	3.7M	324.2K	200.00	20.5K	633.1K
Deferred Income Tax	n/a	n/a	n/a	n/a	22.2K	n/a	n/a
Change in Working Capital	198K	-3.21M	4.37M	710.3K	-394.5K	183.1K	315.8K
Operating Cash Flow	-19.46M	-21.23M	-23.75M	-20.32M	-6.13M	-2.91M	-2.15M
Capital Expenditures	-366K	-206.6K	-4.88M	-1.89M	-1.46M	-302.7K	-137.3K
Cash Acquisitions	n/a	n/a	15K	84K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	15K	-372K	n/a	n/a	n/a
Investing Cash Flow	-366K	-206.6K	-4.87M	-1.81M	-1.46M	-302.7K	-137.3K
Debt Repayment	n/a	23.44M	4.1M	92.2K	468K	250K	725K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	18.41M	-111.2K	-200K	-2.76M	n/a	11.4K	n/a
Financial Cash Flow	18.41M	23.99M	3.9M	37.34M	15.81M	4.76M	1.63M
Net Cash Flow	-1.41M	2.56M	-24.71M	15.2M	8.22M	1.54M	-665.2K
Free Cash Flow	-19.82M	-21.43M	-28.63M	-22.22M	-7.58M	-3.22M	-2.29M